Outcomes of Neoadjuvant Chemotherapy as Treatment for Resectable Malignant Pleural Mesothelioma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the National Cancer Institute
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Role of Neoadjuvant Chemotherapy in Patients With Resectable Malignant Pleural Mesothelioma–An Institutional and National Analysis
J. Natl. Cancer Inst 2020 Nov 01;112(11)1118-1127, SL Voigt, V Raman, OK Jawitz, M Bishawi, CJ Yang, BC Tong, TA D'Amico, DH HarpoleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.